Helga Rübsamen-Schaeff


Meet Helga Rübsamen-Schaeff

Professor Rübsamen-Schaeff was the founder and the CEO of AiCuris, a German Biopharma company dedicated to the research and development of drugs against infectious diseases (viruses and multi-resistant bacteria), from 2006 until 2015. AiCuris´ first drug successfully entered the market. Professor Rübsamen-Schaeff is now Member of AiCuris  Supervisory Board. Before founding AiCuris, Helga Rübsamen-Schaeff was Senior Vice President and Global Head of Anti-Infective Research at Bayer HealthCare from 1994 onwards. She is presently a member of the Board of Partners of E. Merck KG and Chair of Merck´s Research Council as well as a member of the Supervisory Board of 4SC AG.

Professor Rübsamen-Schaeff obtained a chemistry degreefrom the University of Münster in 1971 and a doctorate in 1973 with Herbert Witzel. She performed post-doctoral research in Münster, at Cornell University (Prof. Hess, acetylcholine receptor and biophysical measurements), at the Institute for Medical Virology Gießen (Profs. Bauer & Rott, virology and oncogenes), at the university of Cologne (Institute for Human Virology, head of a working group) and at the Paul Ehrlich Institute in Frankfurt (1981). In 1980s, she was a visiting scientist at Harvard University and specialized in research into the development of cancer and the viruses that play a role in it. In 1983 she habilitated in Frankfurt and from 1982 to 1986 was the head of the Department for Immunotherapy at the Georg-Speyer-Haus chemotherapeutic research institute, where she was managing director from 1987 to 1993. At the Georg-Speyer-Haus she dealt with HIV and oncogenes and succeeded in isolating the first HIV strains in Germany from patients,  showing that the virus occurs in extremely diverse variants and is constantly changing. From 1988 onwards she was a professor of biochemistry and virology at the University of Frankfurt.

She is a member of the National Academy of Sciences of Germany, Leopoldina and of the German Academy of Technical Sciences, acatech.

Scientific Advisory Committee

SAC chair

Peter Piot

Peter Piot is the Handa Professor of Global Health and former Director of the London School of Hygiene & Tropical Medi...
SAC member

Philippe Desmeth

Philippe Desmeth is bioengineer and environmental consultant by training. He is a member of several International Scientif...
SAC member

Isabel Leroux-Roels

Isabel Leroux-Roels is working as a clinical microbiologist and infection control physician at Ghent University Hospital (...
SAC member

Thomas Michiels

Professor Thomas Michiels is full professor at UCL, Belgium (teaching general microbiology, molecular biology, and virolog...
SAC member

Steven Van Gucht

Steven Van Gucht holds a PhD in Veterinary Sciences (virology). He started his career at Sciensano in December 2005 as a S...
SAC member

Alain Vanderplasschen

Alain Vanderplasschen is Professor of Virology and Vaccinology at the Faculty of Veterinary Medicine of the ULiège. He is ...